A Comparison of Clear Cell Sarcoma to Jaw and Salivary Tumors Bearing EWS Fusions

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2024 Mar 25

PMID 38526767

Authors

Ornela Xhori

Navkiran Deol

Camron M Rivera

Jason Zavras

Sophia G Weil

Hirad Zafari

Julia C Thierauf

William C Faquin

Edwin Choy

Miguel N Rivera

A John Iafrate

Alexandre Jaquinet

Maria J Troulis

Affiliations

Soon will be listed here.

Abstract

Objective: To review tumors identified as "clear cell sarcoma" in order to determine similarities to the rare EWS fusion positive jaw and salivary gland tumors clear cell odontogenic carcinoma (CCOC) and clear cell carcinoma of the salivary gland (CCC).

Methods: PubMed was used to collect all reports of clear cell sarcoma (CCS). Search parameters were "clear cell sarcoma" and "CCS." References in the publications were screened and cross-referenced. Data extracted included demographic characteristics, presenting signs and symptoms, radiographic findings, histological and immunohistochemical features and known molecular/genetic aberrations.

Results: Clear cell sarcoma has several similarities to CCOC and CCC. All three tumor types have similar histologic appearances including the presence of clear cells, as well as similar genetic profiles in that all harbor an EWSR1-CREB family fusions. Additionally, these tumors appear in soft tissue as well as bone, and can have a prolonged clinical course. CCS can appear anywhere in the body, including the head and neck region. All three tumors appear to have a predilection to women, although CCS may have a slight younger age of onset as compared to CCOC and CCC (3rd vs 5th decade of life, respectively).

Conclusion: Gaining a better understanding of the similarities and differences between these three tumors may lead to a better understanding of each one.

References

Rodriguez-Martin M, Saez-Rodriguez M, Esquivel B, Gonzaalez R, Cabrera A, Herrera A . Clear cell sarcoma: a case mimicking primary cutaneous malignant melanoma. Indian J Dermatol. 2010; 54(2):168-72. PMC: 2807157. DOI: 10.4103/0019-5154.53193. View

Skalova A, Weinreb I, Hyrcza M, Simpson R, Laco J, Agaimy A . Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol. 2015; 39(3):338-48. DOI: 10.1097/PAS.0000000000000364. View

Segawa K, Sugita S, Aoyama T, Kubo T, Asanuma H, Sugawara T . Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor. Diagn Pathol. 2018; 13(1):73. PMC: 6138919. DOI: 10.1186/s13000-018-0752-6. View

Kar A, Pattnaik K, Kar T, Biswal P, Mishra C, Guru L . Clear cell lesions in pathology: Histomorphologic approach to diagnosis. Indian J Pathol Microbiol. 2020; 63(2):177-187. DOI: 10.4103/IJPM.IJPM_791_19. View

Patil R, Sahu A, Kambalimath H, Panchakshari B, Jain M . Knowledge, Attitude and Practice among Dental Practitioners Pertaining to Preventive Measures in Paediatric Patients. J Clin Diagn Res. 2017; 10(12):ZC71-ZC75. PMC: 5296582. DOI: 10.7860/JCDR/2016/22300.9122. View

Hakozaki M, Tamura H, Dobashi Y, Yoshida A, Kato K, Tajino T . Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination. Anticancer Res. 2018; 38(9):5035-5042. DOI: 10.21873/anticanres.12822. View

Jain A, Shetty D, Juneja S, Narwal N . Molecular Characterization of Clear Cell Lesions of Head and Neck. J Clin Diagn Res. 2016; 10(5):ZE18-23. PMC: 4948555. DOI: 10.7860/JCDR/2016/14394.7867. View

Hisaoka M, Ishida T, Kuo T, Matsuyama A, Imamura T, Nishida K . Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol. 2008; 32(3):452-60. DOI: 10.1097/PAS.0b013e31814b18fb. View

Desai A, Faquin W, Iafrate A, Rivera M, Jaquinet A, Troulis M . Clear cell carcinoma: a comprehensive literature review of 254 cases. Int J Oral Maxillofac Surg. 2021; 51(6):705-712. DOI: 10.1016/j.ijom.2021.03.018. View

Lucas D, Nascimento A, Sim F . Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases. Am J Surg Pathol. 1992; 16(12):1197-204. DOI: 10.1097/00000478-199212000-00006. View

10.

Bilodeau E, Hoschar A, Barnes E, Hunt J, Seethala R . Clear cell carcinoma and clear cell odontogenic carcinoma: a comparative clinicopathologic and immunohistochemical study. Head Neck Pathol. 2011; 5(2):101-7. PMC: 3098331. DOI: 10.1007/s12105-011-0244-4. View

11.

Agrawal J, Kumar Y, Damera D, Kumar S . Clear cell carcinoma of minor salivary gland: A case of clinical dilemma. Contemp Clin Dent. 2014; 5(3):389-92. PMC: 4147820. DOI: 10.4103/0976-237X.137965. View

12.

Komura S, Ito K, Ohta S, Ukai T, Kabata M, Itakura F . Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas. Nat Commun. 2019; 10(1):3999. PMC: 6728361. DOI: 10.1038/s41467-019-11745-1. View

13.

Rivera C, Faquin W, Thierauf J, Afrogheh A, Jaquinet A, Iafrate A . Detection of EWSR1 fusions in CCOC by targeted RNA-seq. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022; 134(2):240-244. DOI: 10.1016/j.oooo.2021.12.127. View

14.

Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W . TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease. Mol Cancer Res. 2019; 17(8):1613-1626. PMC: 6679785. DOI: 10.1158/1541-7786.MCR-18-1235. View

15.

Antonescu C, Tschernyavsky S, Woodruff J, Jungbluth A, Brennan M, Ladanyi M . Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn. 2002; 4(1):44-52. PMC: 1906974. DOI: 10.1016/S1525-1578(10)60679-4. View

16.

Ibrahim R, Steenstrup Jensen S, Juel J . Clear cell sarcoma-A review. J Orthop. 2018; 15(4):963-966. PMC: 6134154. DOI: 10.1016/j.jor.2018.08.039. View

17.

Guastaldi F, Faquin W, Gootkind F, Hashemi S, August M, Iafrate A . Clear cell odontogenic carcinoma: a rare jaw tumor. A summary of 107 reported cases. Int J Oral Maxillofac Surg. 2019; 48(11):1405-1410. PMC: 7422703. DOI: 10.1016/j.ijom.2019.05.006. View

18.

Schoffski P, Wozniak A, Stacchiotti S, Rutkowski P, Blay J, Lindner L . Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'. Ann Oncol. 2017; 28(12):3000-3008. PMC: 5834120. DOI: 10.1093/annonc/mdx527. View

19.

Jacobs I, Chang C, Guzman G, Salti G . Clear cell sarcoma: an institutional review. Am Surg. 2004; 70(4):300-3. View